Showing 19,201 - 19,220 results of 32,143 for search '(( 50 ((a decrease) OR (mean decrease)) ) OR ( e ((nn decrease) OR (point decrease)) ))', query time: 0.66s Refine Results
  1. 19201

    Transfection efficiency and cell proliferation after miR-222-3p expression changes. by Binya Liu (517729)

    Published 2014
    “…Colony formation (≥50 cells) was assessed using a colony counter. Knockdown of miR-222-3p led to a decrease in anchorage-independent colony forming ability of AN3CA cells. * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001.…”
  2. 19202

    Lipid droplet fusion can be triggered specifically by chemicals. by Samantha Murphy (144193)

    Published 2010
    “…Fusogenic reagents caused a decrease in LD number concurrent with an increase in LD radius. …”
  3. 19203

    Gas exchange and millet phytomass under organic fertilization and graywater irrigation by José R. I. Silva (12819968)

    Published 2022
    “…The reduction in irrigation depth caused a decrease in gas exchange from 45 days after the application of the treatments. …”
  4. 19204

    ERK and p38MAPK pathway inhibitors blunted IL-6 protein increase during NGF or BDNF exposure. by Fariba Rezaee (366381)

    Published 2013
    “…BMSC pre-treated with U0126 or SB 203580 demonstrated greater than 50% decrease in IL-6 protein upon exposure to NGF or BDNF. …”
  5. 19205

    EBOV/Mak-C05 Surface Persistence in Cell Culture Media at Three Different Environments. by Michael Schuit (2155819)

    Published 2016
    “…The microtitration assay limit of detection (0.7 Log TCID<sub>50</sub>/mL) is indicated by a gray bar at the bottom of each graph. …”
  6. 19206
  7. 19207

    Citalopram does not increase neural signals for reward or effort outcomes. by Jacqueline Scholl (3752851)

    Published 2017
    “…On the contrary, a more lenient time point—by—time point <i>t</i> test analysis of the time courses revealed that in striatum and vmPFC, citalopram, in fact, decreased the relative reward magnitude outcome signal late in the outcome phase (*<i>p</i> < 0.05 for time point—by—time point two-sided <i>t</i> tests). …”
  8. 19208

    Notch1 deficiency reduces the CTGF-induced collagen gel stiffness in SMCs. by Jaspreet Sachdeva (4057231)

    Published 2017
    “…VSMCs cultured in a 6-well plate and treated with or without CTGF (10 ng/ml) for 72 hours and resuspended in a collagen solution at a concentration of 6 x 10<sup>5</sup> cells/ml for 48 hours. …”
  9. 19209

    Image1_Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data.JPEG by Athanasios Chamzas (19699780)

    Published 2024
    “…The estimated apparent clearance was 13.7 L/h for a typical patient weighing 70 kg and at 30% hematocrit, demonstrating a 40% decrease in clearance compared to other patient populations. …”
  10. 19210

    Table2_Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data.DOCX by Athanasios Chamzas (19699780)

    Published 2024
    “…The estimated apparent clearance was 13.7 L/h for a typical patient weighing 70 kg and at 30% hematocrit, demonstrating a 40% decrease in clearance compared to other patient populations. …”
  11. 19211

    Table1_Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data.DOCX by Athanasios Chamzas (19699780)

    Published 2024
    “…The estimated apparent clearance was 13.7 L/h for a typical patient weighing 70 kg and at 30% hematocrit, demonstrating a 40% decrease in clearance compared to other patient populations. …”
  12. 19212

    Data_Sheet_1_Antiproliferative effect of boldine on neural progenitor cells and on glioblastoma cells.PDF by Enrique Jiménez-Madrona (16836648)

    Published 2023
    “…Analysis of the effect of boldine (25–600 μM) on different types of primary human GBM cells (GBM59, GBM96, and U87-MG) showed a concentration-dependent decrease in GBM cell growth. …”
  13. 19213

    Image2_Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data.JPEG by Athanasios Chamzas (19699780)

    Published 2024
    “…The estimated apparent clearance was 13.7 L/h for a typical patient weighing 70 kg and at 30% hematocrit, demonstrating a 40% decrease in clearance compared to other patient populations. …”
  14. 19214
  15. 19215

    Altered Astrocytic Swelling in the Cortex of α-Syntrophin-Negative GFAP/EGFP Mice by Miroslava Anderova (155561)

    Published 2014
    “…Similarly, evaluation of relative α changes showed a significantly smaller decrease in α-syntrophin knockout mice only during severe pathological conditions, but not during mild stimuli. …”
  16. 19216

    Table1_Baseline Plasma Metabotype Correlates With Direct-Acting Antiviral Therapy Nonresponse for HCV in HIV–HCV Coinfected Patients.XLSX by Gaurav Tripathi (3163251)

    Published 2022
    “…Post therapy, 62 plasma metabolites (12 upregulated and 50 downregulated, FC±1.5, p < 0.05) differentiated nonresponders from responders and highlighted a significant increase in the steroid and histidine metabolism and significant decrease in tryptophan metabolism and ascorbate and pyruvate metabolism in the nonresponders. …”
  17. 19217

    Partial silencing of GFP requires both EhRNaseIII and ScaAgo1. by Justine M. Pompey (268775)

    Published 2015
    “…FACS histogram of GFP fluorescence in the indicated strains show a decrease in GFP fluorescence in strain expressing EhRNaseIII using the strong GFP silencing hairpin but only in the strain expressing ScaAgo1. …”
  18. 19218

    datasheet1_In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis.docx by Dahara Keyse Carvalho Silva (9774635)

    Published 2020
    “…In vitro incubation with LASSBio-1386 reduced the percentage of Leishmania-infected macrophages and the number of intracellular parasites (EC<sub>50</sub> = 9.42 ± 0.64 µM). Also, in vivo treatment of BALB/c mice infected with L. amazonensis resulted in a decrease of lesion size, parasitic load and caused histopathological alterations, when compared to vehicle-treated control. …”
  19. 19219
  20. 19220